About
Joined AdBio in September 2023 with over 25 years in pharma industry in VC-funded biotech start-ups and large corporate organizations. Broad background covering multiple roles with strategic vision for company development. Track record in M&A, in- and out-licensing, and partnerships. Currently CEO of Tridek-One. Board member of Swiss Healthcare Licensing Group since 2013.
Sign up to see Laurence de Schoulepnikoff's full profile
Access investment thesis, focus areas, bio, and contact details for Laurence de Schoulepnikoff and 22,000+ other VC professionals.
AdBio Partners
Paris, FR